Pre-exposure Prophylaxis Accessibility Research and Evaluation 2

Completed · Not applicable

Conditions studied: PrEP Uptake, HIV Seronegativity

In brief

This study is a controlled, un-blinded, two-arm, randomized (1:1) clinical trial to determine if providing high-risk subjects with a calculated risk score changes the likelihood of pre-exposure prophylaxis (PrEP) uptake.

Key facts

Study ID

NCT02125773

Run by

University of California, San Diego

People needed

150

Starts

2014-02-19

Expected to finish

2019-11-08

Last updated by the study team

2020-05-12

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Man or transgender M to F who has sex with men.
• Age 18 years or older.
• Subjects must have substantial ongoing risk of acquisition of HIV as evident by one or more of the following: One or more episode of unprotected anal intercourse with a HIV-infected partner or a partner with unknown HIV status within the last 6 months
• Negative for HIV infection by rapid HIV test

You may not qualify if…

• Unable to give informed consent.
• Signs or symptoms suggestive of acute HIV infection
• Any other reason or condition that in the opinion of the investigator would interfere with participation, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Where it is running

• University of California, San Diego — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.